Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer WithRASandBRAFMutational Status

Author:

Taieb Julien1,Kourie Hampig Raphael1,Emile Jean-François2,Le Malicot Karine3,Balogoun Ralyath45,Tabernero Josep6,Mini Enrico7,Folprecht Gunnar8,Van Laethem Jean-Luc9,Mulot Claire45,Bouché Olivier10,Aparicio Thomas11,Michel Pierre12,Thaler Josef13,Bridgewater John14,Van Cutsem Eric15,Perkins Géraldine15,Lepage Come316,Salazar Ramon17,Laurent-Puig Pierre45,

Affiliation:

1. Sorbonne Paris Cité, Université Paris Descartes, Department of Hepatogastroenterology and GI Oncology, Hôpital Européen Georges Pompidou, Paris, France

2. Pathology Department, Ambroise Paré Hospital, Boulogne-Billancourt, France

3. Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France

4. Université Paris Descartes, Sorbonne Paris Cité, France

5. Assistance Publique–Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, INSERM UMR-S1147, Paris, France

6. Medical Oncology Department, Vall d‘Hebron University Hospital and Institute of Oncology (VHIO), CIBERONC, Universitat Autònoma de Barcelona, Spanish Gastrointestinal Tumours TTD Group, Barcelona, Spain

7. Section of Internal Medicine, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

8. Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany

9. Department of Gastroenterology, Hôpital Universitaire Erasme, Brussels, Belgium

10. Department of Hepato-Gastroenterology, Reims University Hospital, Reims, France

11. Gastroenterology Department, CHU Saint Louis, Assistance Publique–Hôpitaux de Paris and Université Paris 7, Sorbonne Paris Cité, Paris, France

12. Department of Gastroenterology, Rouen University Hospital, University of Rouen, Rouen, France

13. Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria

14. UCL Cancer Institute, University College London, London, England

15. Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, Belgium

16. Hepato-Gastroenterology Department, Dijon University Hospital and INSERM U 866, Dijon, France

17. Catalan Institute of Oncology (IDIBELL), Universitat de Barcelona, CIBERONC, Spanish Gastrointestinal Tumours TTD Group, Barcelona, Spain

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Reference12 articles.

1. Prognostic value of BRAF and KRAS mutations in MSI and MSS stage III colon cancer.;Taieb;J Natl Cancer Inst,2016

2. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.;Arnold;Ann Oncol,2017

3. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.;Taieb;Lancet Oncol,2014

4. Prognostic effect of BRAF and KRAS mutations in patients with stage III colon cancer treated with leucovorin, fluorouracil, and oxaliplatin with or without cetuximab: a post hoc analysis of the PETACC-8 trial. [Published online January 14, 2016].;Taieb;JAMA Oncol

5. Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.;Taieb;Ann Oncol,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3